251 results
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
% Change
Cost of Commercial product sales
Cost of MCM product sales
Cost of Bioservices
Research and development (“R&D”)
Selling, general … activity following the remediation of matters related to the FDA's warning letter, which was closed out in October 2023.
Research and Development
8-K
EX-99.2
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
Funding Figures for key programs ◦ On the biodefense front, these programs received the following appropriations: ▪ Biomedical Advanced Research … and Development Authority (BARDA): $1.015B ▪ Strategic National Stockpile (SNS): $980M ▪ Project BioShield Special Reserve Fund (SRF) $825M International
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
Goodwill impairment
NM
Research and development (“R&D”)
Selling, general and administrative (“SG&A”)
Amortization of intangible assets
Total … at the Company’s Camden and Winnipeg facilities.
Research and Development Expenses
For Q4 2023, R&D expenses decreased $17.6 million, or 37
8-K
EX-10.1
159zznc 48
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
8-K
4zjuk7q9274eg gotsf
28 Nov 23
Other Events
7:15am
8-K
EX-99.1
e89p3sfhd z4g6ofebgt
28 Nov 23
Other Events
7:15am
8-K
EX-99.1
nandzs ml9y8
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.2
hhcuf86y1rym
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.1
fwldgujp39ae8ikpd0
8 Aug 23
Emergent Biosolutions Reports Financial Results for Second Quarter 2023
4:12pm
8-K
pt00hc59abfbgx
31 Jul 23
Other Events
4:26pm
8-K
EX-99.1
3hdvf2md xh
31 Jul 23
Other Events
4:26pm
8-K
EX-99.1
4ivdvx5 m2rn5bv2e2e
21 Jul 23
Regulation FD Disclosure
8:25am
8-K
EX-10.1
1mjkt
17 May 23
Emergent’s Statement Regarding its Amended Credit Agreement
9:32pm
8-K
EX-99.2
52u1hdnn
15 May 23
Completion of Acquisition or Disposition of Assets
8:01am